BeStock  
Stocks › Biotechnology › TSHA

Taysha Gene Therapies TSHA

US equityMarket cap rank #3032Biotechnology
$3.72 −$0.05 (-1.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.71 -0.27%
Open$3.67
Prev close$3.77
Day range$3.60 – $3.80
Volume3.15M
Market cap$1.21B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$14.33+285.2% vs. price
  • Buy 100%
Low $12.00Now $3.72Avg $14.33High $17.00

Recent rating changes

The last 20 actions on file set price targets from $10.00 to $19.00, averaging $13.39.

DateFirmRatingTarget
13 Nov 2026 CCORF BUY $17.00
13 Nov 2026 BMO Capital BUY $14.00
16 Oct 2026 Piper Sandler BUY $12.00
17 Sep 2026 Wolfe Research BUY –
14 Aug 2026 BofA Securities BUY –
12 Aug 2026 Piper Sandler BUY $12.00
12 Aug 2026 Needham BUY $12.00
11 Aug 2026 Cantor Fitzgerald BUY $19.00
11 Aug 2026 CCORF BUY $17.00
11 Aug 2026 Goldman Sachs BUY $13.00
20 Jul 2026 Goldman Sachs BUY $13.00
1 Jul 2026 Needham BUY $12.00
30 Jun 2026 Piper Sandler BUY $12.00
30 Jun 2026 Baird BUY $15.00
30 Jun 2026 Needham BUY $12.00
30 Jun 2026 BMO Capital BUY $14.00
23 Jun 2026 Citizens JMP BUY $11.00
23 Jun 2026 BMO Capital BUY $14.00
22 Jun 2026 BofA Securities BUY $10.00
22 Jun 2026 Needham BUY $12.00

Discussion

No comments yet — be the first to weigh in on TSHA.

Sign in to join the discussion.

Scroll to Top